Corcept Therapeutics Inc
Change company Symbol lookup
Select an option...
CORT Corcept Therapeutics Inc
CVS CVS Health Corp
NVAX Novavax Inc
MRK Merck & Co Inc
HYT BlackRock Corporate High Yield Fund, Inc
FNMA Federal National Mortgage Association
CPKF Chesapeake Financial Shares Inc
AGNC Agnc Investment Corp
BYND Beyond Meat Inc
NDENF Central African Gold Inc

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive antagonist at the glucocorticoid receptor (GR). As of December 31, 2016, it had discovered three structurally distinct series of selective cortisol modulators, all of which share mifepristone's affinity for GR but, unlike mifepristone, do not bind to the progesterone receptor. It is conducting two clinical trials of its selective cortisol modulator, CORT125134. One trial is investigating CORT125134 as a treatment for patients with Cushing syndrome. The second trial is investigating the combination of CORT125134 and nab-paclitaxel (Celgene Corporation's Abraxane) to treat patients with solid-tumor cancers.

Closing Price
Day's Change
-0.30 (-1.67%)
B/A Size
Day's High
Day's Low

10-day average volume:

Penguin Computing Expands Contributions to AMD COVID-19 HPC Fund

8:03 am ET October 6, 2020 (Globe Newswire) Print

Penguin Computing, a subsidiary of SMART Global Holdings, Inc. (NASDAQ: SGH) and leader in high-performance computing (HPC), artificial intelligence (AI), and enterprise data center solutions, today announced the expansion of its collaboration with technology partners AMD (NASDAQ: AMD) and DataBank, to deliver HPC capabilities to accelerate medical research and contribute to a greater understanding of the novel coronavirus.

In June, Penguin Computing was selected by AMD to architect, build, deliver and support cloud resources and on-premises systems for COVID-19 related research. Penguin Computing previously welcomed researchers from New York University (NYU), Massachusetts Institute of Technology (MIT) and Rice University to the COVID-19 HPC Fund. Now, the first petaflop of cloud-based compute capacity is online and available for researchers to access for pandemic-related research in Penguin Computing's data center.

The complete cloud deployment includes four petaflops of AMD GPU resources along with the high-speed storage and low-latency networks that COVID-19 research applications require. The user experience on the cluster will be enhanced by Penguin Computing's comprehensive Scyld Software suite. These software tools provide provisioning, administration, remote visualization, and cloud orchestration that deliver an engagement that is highly-tuned for HPC workloads. Penguin Computing's POD resources are collocated in specialized high-density data center facilities donated by DataBank.

The AMD COVID-19 HPC Fund has also added 18 new institutions that will receive AMD-powered, high-performance computing systems delivered by Penguin Computing and through access to Penguin Computing On-Demand (POD) cloud-based resources. These clusters are all powered by 2 Gen AMD EPYC and AMD Radeon Instinct processors. Researchers from University of Texas, University of Toronto, Stanford, UCLA, and 14 other institutions in the U.S. and Europe are among those joining the Fund.

"Penguin Computing is honored by the opportunity to expand our support and contributions to the COVID-19 research efforts through this important collaboration with AMD and Databank. We are committed to providing leading applications and technology expertise in high-performance computing, artificial intelligence and data analytics to both the on-premises and remote POD cloud environments that will accelerate critical research initiatives," said Sid Mair, President, Penguin Computing.

"AMD is proud to be working with these leading research institutions to apply high performance computing technology in the fight against the coronavirus pandemic. Together, we will deepen our understanding of current and future threats to global health, and improve the world's ability to respond," said Scott Aylor, corporate VP, AMD global manufacturing strategy and executive sponsor of the AMD COVID-19 HPC Fund. "We thank our technology partners for joining us in giving researchers access to this tremendous compute capacity."

"No one knows how to build and deploy an HPC platform like Penguin Computing. We're pleased to announce our continued participation in this important alliance with Penguin Computing and AMD to enable and accelerate scientific research on COVID-19 and other diseases," said Raul K. Martynek, CEO, DataBank.

Follow Penguin Computing on Twitter @PenguinHPC and use our official hashtags #HPCeverywhere and #AIeverywhere to stay connected.

About Penguin Computing

For 20 years, the Penguin Computing team of artificial intelligence (AI), engineering, and computer science experts has reimagined how startups, Fortune 500, government, and academic organizations solve complex technology challenges and achieve their organizational goals. Penguin Computing is focused on open platforms, including Open Compute Project (OCP) systems. We specialize in innovative high-performance computing (HPC), cloud, AI, and storage technologies coupled with leading-edge design, implementation, hosting and managed services including sys-admin and storage-as-a-service, all with highly rated customer support. More information at

Penguin Computing, Inc. is a subsidiary of SMART Global Holdings Inc., (NASDAQ: SGH).

Penguin Computing Media Contacts

Karbo Communications

Madeline Kalicka

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.